Terumo India has expanded its interventional cardiology portfolio with the launch of the FineCross M3 Coronary Micro-Guide Catheter, a next-generation device designed to enhance procedural success in complex percutaneous coronary interventions (PCI).
Engineered to deliver superior crossing performance and guidewire support, the FineCross M3 is tailored for navigating challenging coronary anatomies. The catheter features a 1.7 Fr tapered distal tip for improved lesion crossability, a 15 cm floppy distal segment that ensures trackability through tortuous vessels, and a tapered stainless-steel braided shaft for optimised pushability and control. It also comes equipped with a next-generation hydrophilic coating for smoother movement and a PTFE inner layer with a radio paque marker to enable precise visualisation and device delivery.
Speaking about the launch, Shishir Agarwal, President and Managing Director of Terumo India, said,
“Innovation at Terumo India is driven by our commitment to help physicians deliver the best possible care. The introduction of FineCross M3 brings a globally trusted innovation to Indian cardiology and reinforces our promise of an unwavering commitment to patients.”
Highlighting the clinical importance of the device, Nitin Stephen Abel, Senior Director of Terumo Interventional Systems, added,
“FineCross M3 is more than just a new product it represents our dedication to advancing cardiovascular care in India. Through cutting-edge innovations, we aim to empower clinicians and improve patient outcomes, aligning with Terumo’s mission of contributing to society through healthcare.”
With the FineCross M3, Terumo India continues to strengthen its leadership in cardiovascular solutions, supporting interventional cardiologists with technology that enhances precision, safety, and patient care.
